The Spanish Association of Orphan and Ultra Orphan Medicinal Products Laboratories (AELMHU) has re-elected María José Sánchez Losada as president, following elections to its Board of Directors.
This re-election, which comes at the end of the two-year regular term of office established in the Association's statutes, represents the unanimous support of the General Assembly for the policies and management of Sánchez Losada, whose project aims to contribute to improving the situation of people and families affected by rare or infrequent diseases, promoting knowledge of their pathologies and the recognition of the therapeutic and social value of Orphan Drugs.
The new Board of Directors is completed with José Luis Moreno Sánchez, as vice-president; David Moreno Alforcea, secretary and member; Sergio Bullón Avendaño, as treasurer and member; and Jordi Casals Ferragut, as member.
Go to the press release
